The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer's disease.
scientific article published on 12 February 2018
Author/s
author: Susan E. Boehnke, Letícia Forny-Germano, Brian C. Coe, Christian Hölscher, Fernanda De Felice, Sérgio Teixeira Ferreira, William L. Klein, Julia R Clarke, Jordano Brito-Moreira, Jean C Houzel, André F Batista
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.